Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Microdermis Corporation logo — company profile

Microdermis Corporation

Founded 2010 United States Princeton, United States 1 employees Debt Financing Biotechnology, Health and Wellness +1

General Information

Company Name Microdermis Corporation
Founded Year 2010
Location United States Princeton, United States +1
Founders / Decision Makers
Team member
Employees 1
Industries Biotechnology, Health and Wellness, Manufacturing
Funding Stage Debt Financing
Social

Get notified when Microdermis Corporation moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Microdermis Corporation

Microdermis Corporation is a life sciences company that stands out with its innovative delivery platform. The company focuses on developing novel drug, device, and healthcare products that incorporate proven active ingredients with its unique Amidermal® delivery system. This results in products that offer enhanced performance, lower manufacturing costs, and faster time-to-market. Currently, with a pipeline of products in commercial development, Microdermis targets both military and civilian applications of its technologies, spanning both the US and international markets. The company's flagship product, Provodine®, represents a next-generation professional antiseptic. Meeting or exceeding FDA requirements for various uses such as Surgical Scrub, Pre-Operative Skin Preparation, Healthcare Personnel Hand Wash, and First Aid Antiseptic, Provodine utilizes Microdermis' unique Amidermal technology to achieve enhanced kill strength against the most dangerous microbes. Notably, there are currently no known resistant strains to Provodine, making it particularly effective for utilization in challenging environments like military field hospitals and with globally-deployed NGO personnel. The Amidermal technology also extends the potency window of the active ingredient, with persistence exceeding 6 hours. Furthermore, Provodine contains a proprietary blend of ingredients that not only offer remarkable antimicrobial performance but also nourish and rebuild the skin, addressing concerns such as dryness and cracking. This is significant as healthy skin leads to better compliance with hand hygiene protocols, reinforcing the value proposition of the product. The last known investment in Microdermis Corporation was a Debt Financing investment on 29th December 2015. Although specific details regarding the investors and the amount remain undisclosed, given the company's innovative approach to addressing critical healthcare needs and its proven track record, it presents an intriguing prospect for potential investors and stakeholders in the life sciences and healthcare sectors.

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Debt Financing •••••• - 29 Dec 2015
Debt Financing •••••• - 27 Aug 2015
Seed •••••• - 25 Nov 2014
Venture - Series Unknown •••••• - 04 Sep 2012
Convertible Note •••••• - 13 May 2011

View All 6 Funding Rounds

Microdermis Corporation Alternatives & Competitors

Microdermis Corporation vs
Mega Disposables S.A.
Mega Disposables S.A. Greece

From Inspiration to Innovation

124 employees
Consumer Goods, Manufacturing
Microdermis Corporation vs
U.SK Under Skin
U.SK Under Skin United States

Science Behind The Beauty

5 employees
Health and Wellness, Industrial
Microdermis Corporation vs
OLIVIE
OLIVIE Greece

Nowadays Pure Organic Olive Oil, constitutes not only the basic component of the Mediterranean diet,...

1 employees

FAQ About Microdermis Corporation

Microdermis Corporation, a life sciences company with an innovative delivery platform, focuses on the development of novel drug, device and healthcare products that combine known, proven active ingredients with its unique Amidermal® delivery system to produce compelling products with significantly-e...
Microdermis Corporation was founded in 2010.
Microdermis Corporation is headquartered in Princeton, United States.
Microdermis Corporation operates in the following industries: Biotechnology, Health and Wellness, Manufacturing.
Microdermis Corporation has approximately 1 employees.
Microdermis Corporation has completed 6 funding rounds. The latest funding stage is Debt Financing.
Top alternatives and competitors to Microdermis Corporation include Mega Disposables S.A., U.SK Under Skin, OLIVIE, Concept Matrix Solutions, Inc., MPM Medical. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Microdermis Corporation and Mega Disposables S.A. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Microdermis Corporation and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy